15
May

MDR TB in Myanmar

Here is an article on MDR TB in Myanmar.

Jamie

++++++++++++++++++

High treatment success rate among multidrug-resistant tuberculosis patients in Myanmar, 2012–2014: a retrospective cohort study
Myat K Thu Ajay M V Kumar Kyaw T Soe Saw Saw Saw Thein Zaw Mynit Htet M W Maung Si T Aung
Transactions of The Royal Society of Tropical Medicine and Hygiene, Volume 111, Issue 9, 1 September 2017, Pages 410–417, https://doi.org/10.1093/trstmh/trx074

Abstract
Background
Since 2011, Myanmar has adopted domiciliary care for multidrug-resistant tuberculosis (MDR-TB) patients and implemented several patient-support measures such as community-based directly observed treatment, nutritional support and financial incentives for patients and providers. We assessed treatment outcomes among MDR-TB patients registered for treatment in the Yangon and Mandalay Regions of Myanmar during 2012–2014 and factors associated with unfavourable treatment outcomes.

Methods
We performed a retrospective cohort study involving secondary analysis of routine programmatic data extracted from the electronic MDR-TB treatment registries. We calculated the adjusted risk ratio (aRR) and 95% confidence interval (CI).

Results
Of 2185 MDR-TB patients (75% HIV tested, 14% HIV positive with 70% of them receiving antiretroviral therapy), 1746 (80%) were successfully treated (cured and treatment completed) and 20% had unfavourable outcomes (14% died, 3% lost to follow-up, 2% failure and 1% not evaluated). Compared with young patients (<25 y), patients 25–54 y of age (aRR 2.0 [95% CI 1.3 to 2.9]) and >55 y (aRR 3.2 [95% CI 2.1 to 4.8]) were more likely to have unfavourable outcomes. HIV-positive patients (especially not receiving ART; aRR 2.2 [95% CI 1.4 to 3.6]) and patients with ‘unknown HIV status’ (aRR 1.9 [95% CI 1.5–2.4]) had a higher risk of unfavourable outcomes compared with HIV-negative patients.

Conclusions
Treatment success was high and deaths accounted for three-fourths of unfavourable outcomes. Joint care and management of MDR-TB and HIV co-infected patients should be strengthened.

https://academic.oup.com/trstmh/article/111/9/410/4812608

https://twitter.com/MENTOR_Hq/status/977590928042090497

Leave a Reply

Your email address will not be published. Required fields are marked *

Captcha *

Follow me on:

Back to Top